Longeveron Inc.

Analysis for Ticker: LGVN

Longeveron Inc is a biotechnology company developing cellular therapies for rare pediatric heart conditions, Alzheimer disease, and aging frailty. The math is a disaster because the company lost 22,7$ million in a single year while its cash plummeted to only 4,7$ million before a desperate financing round. They are surviving by printing millions of new shares and selling them to institutional funds for pennies while using that same cash to pay back their own salaries and cover their personal tax liabilities. To a child, this is like a lemonade stand that sells no lemonade but constantly asks parents for more money to pay the kids' allowances and their tax bills until the parents have nothing left.